![Dark Drug Science Logo Dark Drug Science Logo](https://darkdrug.com/wp-content/uploads/2016/06/DD-Pharma-Logo.png)
Pharma
“Medicine is the restoration of discordant elements; sickness is the discord of the elements infused into the living body.” - Leonardo da Vinci![Blockchain Revolutionizing the Pharmaceutical Industry: Ensuring Transparency, Security and Efficiency](https://darkdrug.com/wp-content/uploads/2024/06/AdobeStock_779741338-scaled-e1718958073598-1080x675.jpeg)
Blockchain Revolutionizing the Pharmaceutical Industry: Ensuring Transparency, Security and Efficiency
Blockchain technology has emerged as a game-changer in various sectors, and the pharmaceutical industry is no exception. With its decentralized and transparent nature, blockchain holds tremendous potential to revolutionize drug development, supply chain management, clinical trials, and patient data security
The UK’s Prescription for the Future?
The Life Sciences sector now finds itself facing intensifying global competition, with other nations aggressively courting the industry's prized assets and expertise. Meanwhile, the National Health Service (NHS) has grappled with the dual challenge of constrained budgets and the rising costs of newer, more innovative medicines
The Importance of Accurate and Balanced Promotional Claims: Lessons from the PMCPA Trelegy Case
In the highly competitive pharmaceutical industry, companies must carefully navigate the complex regulatory landscape when promoting their products. A recent case ruling by the Prescription Medicines Code of Practice Authority (PMCPA) highlights the importance of ensuring promotional claims are accurate, balanced and supported by robust evidence.
The Promise of CAR T-Cells: Progress and Challenges in Cancer Immunotherapy
Over a decade since the first clinical trials began, long-term follow-up data have affirmed CAR T-cells’ ability to induce durable remissions in certain patients. However, the therapy also faces challenges, as not all treated cancers respond equally well and toxicity remains a concern. Ongoing research aims to optimize various aspects of CAR T-cell treatment to improve outcomes on a broader scale.
A New Purpose for an Old Drug
Researchers at Creighton University may have discovered a new use for the antiviral Oseltamivir (Tamiflu) that could help many more people at risk of hearing impairment.
Antibodies Revolutionizing Cancer Care: Past Successes and Future Promise
Antibody-based therapies have transformed cancer treatment over the past few decades. A recent review published in Nature Reviews Cancer provides a comprehensive overview of the progress made to date and the exciting new frontiers on the horizon
Why Are Medical Staff Liasions’s Interactions Different?
The ruling on this PMCPA case from December 2023 raises several discussions points around providing clarity for medical liaison staff and their interactions at conferences
Ensuring Accuracy of Prescribing Information in Today’s Digital Landscape
This case illuminates pharmaceutical companies' indispensable duty to diligently oversee processes updating drug learning and prescribing materials as product knowledge progresses.
AI | MHRA – Harnessing New Technology While Ensuring Public Safety?
While AI promises major benefits like faster treatment, more personalized care, and improved access to treatment, it also risks introducing new challenges if not properly governed. The Medicines and Healthcare products Regulatory Agency (MHRA) faces the complex task of enabling innovation while protecting patients
AI | Artificial Intelligence and the Future of Healthcare – EFPIA
The European Federation of Pharmaceutical Industries and Associations (EFPIA) outlines their vision for maximizing the benefits of AI while ensuring patient safety and privacy. This postion paper is for consideration by legislators and regulators of the emerging AI frameworks.
Lessons for Pharma from a Pre-Approval Social Media Misstep
One ill-advised retweet over two years ago regarding data for an unapproved product has resulted in significant learnings for Pfizer and the pharmaceutical industry about the careful boundaries of using social media
![](https://darkdrug.com/wp-content/uploads/2017/05/DARK-DRUG-FEEDS.png)
- New understanding of fly behavior has potential...on July, 2024 at 3:34 pm
Scientists have identified an automatic behavior in flies that helps them assess wind conditions -- its presence and direction -- before deploying a strategy to follow a scent to its source. The fact that they can do this is surprising -- can you tell if there's a gentle breeze if you stick your […]
- A rare form of ice at the center of a cool new...on July, 2024 at 3:33 pm
Researchers explain a new mechanism for ice formation. Ice can form near the free surface of a water droplet via small precursors with a structure resembling ice 0. These are readily formed by negative pressure effects due to surface tension, creating ring-like structures with the same […]
- Researchers develop state-of-the-art device to...on July, 2024 at 3:33 pm
Engineering researchers have demonstrated a state-of-the-art hardware device that could reduce energy consumption for artificial intelligent (AI) computing applications by a factor of at least 1,000.
- Folded peptides are more electrically conductive...on July, 2024 at 11:39 pm
What puts the electronic pep in peptides? A folded structure, according to a new study. Researchers combined single-molecule experiments, molecular dynamics simulations and quantum mechanics to validate the findings.
- 'Kink state' control may provide pathway to...on July, 2024 at 11:39 pm
The key to developing quantum electronics may have a few kinks. According to researchers, that's not a bad thing when it comes to the precise control needed to fabricate and operate such devices, including advanced sensors and lasers. The researchers fabricated a switch to turn on and off the […]
After 11 years, Boston Dynamics has said goodbye to its humanoid robot ATLAS HD. The robotics company says it’s time for ATLAS to “kick back and relax” in retirement, letting the new all electric ATLAS take over. This video was shared to remember ATLAS HD’s great moments and those not so great.
Header Banner: AZT the development name for zidovudine was the first drug launched to treat HIV. It was used in high doses and as monotherapy, causing horrendous side effects and resistance in the HIV virus. In the subsequent 30 years clinical trials has led to the development of single tablet, once daily regimens to treat HIV with limited side effects. Now a two pill combination called Truvada can be given to individuals to prevent the risk of acquiring HIV (shown in the DarkDrug logo).